89Zr-DFO-huJ591
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-DFO-huJ591, covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer [Phase 1, Phase 2]